BS-FU01 Follow-Up Study of FluBHPVE6E7 Study Subjects

Phase II Study of Treatment for HPV16+ ASC-US, ASC-H and LSIL

NCT03911076 ·Status: TERMINATED ·Phase: PHASE2

The Safety and Effectiveness of Cidofovir in the Treatment of Venereal Warts in HIV-Infected Patients

NCT00002327 ·Status: COMPLETED ·Phase: PHASE1

Immunogenicity Study of the Recombinant Human Papillomavirus Virus Type 6/11 Bivalent Vaccine

NCT02710851 ·Status: UNKNOWN ·Phase: PHASE2

Cnidium Monnieri Detoxification Formula for Persistent High-risk Human Papillomavirus Infection of Cervix.

NCT06705322 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

On the Impact of Therapeutic Tumor Necrosis Factor-alpha Inhibition on Anogenital Human Papillomavirus Infection

NCT02376478 ·Status: COMPLETED

Candida Antigen and Bivalent HPV Vaccine in the Treatment of Multiple Warts

NCT05291845 ·Status: RECRUITING ·Phase: PHASE2

Study to Evaluate the Safety and Efficacy of KITE-439 in HLA-A*02:01+ Adults With Relapsed/Refractory HPV16+ Cancers

NCT03912831 ·Status: TERMINATED ·Phase: PHASE1

Study of 2LPAPI® on the Clearance of Genital HR-HPV Infections.

NCT04232917 ·Status: RECRUITING ·Phase: PHASE4

HPV-16/18 E6/E7-Specific T Lymphocytes, Relapsed HPV-Associated Cancers, HESTIA

NCT02379520 ·Status: COMPLETED ·Phase: PHASE1

Natural History of Human Papillomavirus (HPV) Infections in Mid-Adult Women (WHIM)

NCT01295242 ·Status: COMPLETED

Clinical Study of HPV Therapeutic DNA Vaccine (NWRD08) in Patients With Cervical HPV16 and/or HPV18 Positive

NCT05905354 ·Status: UNKNOWN ·Phase: NA

A Study HB-201 in Patients With Newly Diagnosed HPV16+ Oropharynx or Locally Advanced Cervical Cancer

NCT04630353 ·Status: TERMINATED ·Phase: EARLY_PHASE1

Evaluation of NWRD08 for HPV-16 and/or HPV-18 Related Cervical HSIL

NCT07175662 ·Status: RECRUITING ·Phase: PHASE2

Efficacy of Quadrivalent HPV Vaccine to Prevent Relapses of Genital Warts After Initial Therapeutic Response

NCT03296397 ·Status: UNKNOWN ·Phase: PHASE3

NWRD08 DNA Plasmid for HPV-16 and/or HPV-18 Related Cervical HSIL

NCT06276101 ·Status: RECRUITING ·Phase: PHASE1

Study of Oral Papillomavirus In Teens and Twenties

NCT00994019 ·Status: COMPLETED

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Topical Applications of AP611074 5% Gel for up to 16 Weeks in Condyloma Patients

NCT02724254 ·Status: COMPLETED ·Phase: PHASE2

Safety, Tolerability, and Immunogenicity of GTL001 Vaccine Adjuvanted With Imiquimod Cream in HPV 16- and/or HPV 18-Infected Women Aged 25 to 65 Years, With Normal Cytology, ASCUS, or LSIL

NCT02689726 ·Status: TERMINATED ·Phase: PHASE1

Hespecta Vaccination in HPV+ Tumors or Malignant Lesions

NCT02821494 ·Status: COMPLETED ·Phase: PHASE1

Broad Spectrum HPV Vaccine Dose Escalation Study (V502-002)

NCT00851643 ·Status: COMPLETED ·Phase: PHASE1

To Evaluate the Safety and Immunogenicity of 15-valent HPV Recombinant Vaccine in Chinese People Aged 9-45 Years

NCT06756269 ·Status: RECRUITING ·Phase: PHASE2

Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of the Oncolytic HSV1 MVR-C5252

NCT06126744 ·Status: RECRUITING ·Phase: PHASE1

NWRD09 for HPV-16 Related Cervical HSIL

NCT07047989 ·Status: RECRUITING ·Phase: PHASE1

Human Papilloma Virus Genotypes and Treatment Outcomes of Intralesional Immunotherapy of Anogenital Warts

NCT05761002 ·Status: UNKNOWN ·Phase: NA

AV2 Antiviral Spray Versus Placebo in Human Papillomavirus Cervix Infections

NCT01654822 ·Status: UNKNOWN ·Phase: PHASE2